Literature DB >> 32496823

What place does molecular topology have in today's drug discovery?

Riccardo Zanni1,2, Maria Galvez-Llompart1,3, Ramon Garcia-Domenech1, Jorge Galvez1.   

Abstract

INTRODUCTION: Most methods in molecular and drug design are currently based on physicochemical descriptors. However, molecular topology, which relies on topological descriptors, has also shown value for molecular design even if it does not take into account the physical or chemical properties of ligands and receptors, including the ligand-receptor interaction itself. AREAS COVERED: Herein, the authors provide new insights into the importance of molecular topology according to some of the latest discoveries in physics and chemistry. Furthermore, the authors report on the most significant achievements in drug design using molecular topology over the last 5 years and give their expert perspectives on the subject as a whole. EXPERT OPINION: Molecular topology is a new paradigm which is independent of physicochemical molecular descriptors. This fact explains the viability of both the discovery of new lead compounds with a minimum of information derived from mathematical-topological patterns and the interpretation results in structural and physicochemical terms.

Keywords:  Molecular topology; QSAR; computer aided drug design; drug design; molecular design

Mesh:

Substances:

Year:  2020        PMID: 32496823     DOI: 10.1080/17460441.2020.1770223

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  4 in total

1.  Recurrent neural network (RNN) model accelerates the development of antibacterial metronidazole derivatives.

Authors:  Nannan Chen; Lijuan Yang; Na Ding; Guiwen Li; Jiajing Cai; Xiaoli An; Zhijie Wang; Jie Qin; Yuzhen Niu
Journal:  RSC Adv       Date:  2022-08-15       Impact factor: 4.036

2.  COVID-19 and the Importance of Being Prepared: A Multidisciplinary Strategy for the Discovery of Antivirals to Combat Pandemics.

Authors:  Maria Galvez-Llompart; Riccardo Zanni; Jorge Galvez; Subhash C Basak; Sagar M Goyal
Journal:  Biomedicines       Date:  2022-06-07

3.  How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease.

Authors:  Maria Galvez-Llompart; Riccardo Zanni; Ramon Garcia-Domenech; Jorge Galvez
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-14

4.  Chitin Deacetylase, a Novel Target for the Design of Agricultural Fungicides.

Authors:  Jesús M Martínez-Cruz; Álvaro Polonio; Riccardo Zanni; Diego Romero; Jorge Gálvez; Dolores Fernández-Ortuño; Alejandro Pérez-García
Journal:  J Fungi (Basel)       Date:  2021-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.